Maxidauno
THERAPEUTIC AREA: Oncology / Hematology + Onco-Hematology
ACTIVE PRINCIPLE: Daunorubicin
PRESENTATION: Lyophilized Powder
INDICATION:
- Acute Lymphocytic Leukemia
COUNTRIES WHERE IT IS MARKETED:
